Variable | GI dysfunction (n = 149) | Non-GI dysfunction (n = 179) | P-value |
---|---|---|---|
Age (years, mean ± SD) | 41.8 ± 14.2 | 41.4 ± 13.0 | 0.819 |
Weight (kg, mean ± SD) | 66.1 ± 11.1 | 66.3 ± 12.7 | 0.920 |
Sex [n(%)] | Â | Â | 0.865 |
 Male | 112 (75.2) | 136 (76.0) |  |
 Female | 37 (24.8) | 43 (24.0) |  |
Injury source [n(%)] | Â | 0.228 | |
 Fire | 112 (75.2) | 131 (73.2) |  |
 Chemicals | 26 (17.4) | 27 (15.1) |  |
 Hot liquid | 4 (2.7) | 14 (7.8) |  |
 Electricity | 7 (4.7) | 7 (3.9) |  |
Inhalation injury [n(%)] |  | < 0.001 | |
 Yes | 112 (75.2) | 90 (50.3) |  |
 No | 37 (24.8) | 89 (49.7) |  |
Trauma at admission [n(%)] | Â | 0.374 | |
 Yes | 12 (8.1) | 10 (5.6) |  |
 No | 137 (91.9) | 169 (94.4) |  |
Shock at admission [n(%)] | Â | 0.017 | |
 Yes | 71 (47.7) | 62 (34.6) |  |
 No | 78 (52.3) | 117 (65.4) |  |
Incidence separated on % TBSA [n(%)] |  | < 0.001 | |
 20–29 | 9 (6.0) | 12 (6.7) |  |
 30–49 | 19 (12.8) | 58 (32.4) |  |
 50–69 | 36 (24.2) | 57 (31.8) |  |
 70–89 | 49 (32.9) | 38 (21.2) |  |
 ≥ 90 | 36 (24.2) | 14 (7.8) |  |
% TBSA [M (Q1, Q3)] | 75 (52, 89) | 52 (35, 70) | < 0.001 |
% full-thickness TBSA [M (Q1, Q3)] | 35 (14, 59) | 14 (2, 34) | < 0.001 |
Baux score [M (Q1, Q3)] | 128 (102, 146) | 105 (83,127) | < 0.001 |
SOFA score [M (Q1, Q3)] | 3 (1, 5) | 2 (1, 3) | < 0.001 |
ABSI score [M (Q1, Q3)] | 11 (9, 13) | 10 (8, 12) | 0.023 |
WBC [× 109/L, M (Q1, Q3)] | 16.7 (10.3, 22.3) | 13.1 (10.0, 18.1) | 0.009 |
CRP [mg/ml, M (Q1, Q3)] | 57.0 (18.8, 112.0) | 56.8 (23.5, 117.8) | 0.679 |
Platelet [× 109/L, M (Q1, Q3)] | 205 (117, 301) | 203 (131, 306) | 0.752 |
ALB [g/L, M (Q1, Q3)] | 28.0 (23.8, 34.6) | 29.1 (25.6, 36.0) | 0.048 |
Sepsis* [n(%)] |  |  |  < 0.001 |
 Yes | 68 (45.6) | 39 (21.8) |  |
 No | 81 (54.4) | 140 (78.2) |  |
Wound infection [n(%)] | Â | Â | 0.227 |
 Yes | 38 (25.5) | 55 (30.7) |  |
 No | 111 (74.5) | 119 (66.5) |  |
High MME requirement [n(%)] | Â | 0.283 | |
 Yes | 31 (20.8) | 29 (16.2) |  |
 No | 118 (79.2) | 150 (83.8) |  |
MME [mg, M (Q1, Q3)] | 196.0 (70.0, 506.0) | 138.0 (47.5, 348.8) | 0.010 |
Continuous analgesia with opioids [n(%)] | Â | 0.078 | |
 CIA | 74 (49.7) | 71 (39.7) |  |
 PCA | 17 (11.4) | 16 (8.9) |  |
 None | 58 (38.9) | 92 (51.4) |  |